Component 8: Zorrilla
第 8 部分:索里拉
基本信息
- 批准号:8374917
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-01 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAddictive BehaviorAffectAffectiveAffective SymptomsAlcohol consumptionAlcohol withdrawal syndromeAmygdaloid structureAnti-Anxiety AgentsAnxietyBehaviorBehavioralBrainBrain regionCellular NeurobiologyChronicCorticotropin-Releasing HormoneDataEthanolEthanol dependenceFundingImmunoassayIndividualIntakeLateralLigandsMaintenanceMicroinjectionsModelingNeurobiologyNeuropeptide Y ReceptorPeptidesPropertyRattusRecording of previous eventsRelapseResearchRoleSelf-AdministeredSeptum of BrainSignal TransductionSiteSpecificityStagingStressSymptomsSystemTechniquesTestingTimeWithdrawalWithdrawal Symptomalcohol abstinencealcohol effectalcohol exposurealcohol reinforcementalcohol researchbinge drinkingdesigndrinkingmultidisciplinaryneuroadaptationneurochemistryneuropeptide Ypreventreceptortherapeutic developmentvaporward
项目摘要
As ethanol dependence develops, intake transitions from controlled drinking to uncontrolled, compulsive, and excessive intake. Neuroadaptations that result from chronic, heavy ethanol use ("binge-like drinking") are hypothesized to drive this progression, leading to the emergence of relapse-motivating negative affect upon cessation of intake. Ethanol intake thereby becomes compelled for its negative reinforcing properties -- to ward off or relieve affective withdrawal symptoms. Time course studies suggest that acute and late protracted abstinence are distinct stages of withdrawal that motivate drinking and whose neurobiological underpinnings remain unclear. Behavioral and neurochemical data implicate roles for dysregulated extrahypothalamic corticotropin-releasing factor (CRF) and neuropeptide Y (NPY) function in affective withdrawal symptoms. The overarching hypothesis of the present application is that chronic heavy ethanol use leads to increases in anxiogenic extrahypothalamic CRF! or Y2 signaling and decreases in anxiolytic Yi activity, each of which contributes to "passive" anxiety behaviors during protracted ethanol abstinence. SPECIFIC AIM 1 will determine whether a chronic history of self-administered binge drinking leads to increased anxiety-like behavior upon acute or protracted ethanol withdrawal. SPECIFIC AIM 2 will determine
whether rats rendered ethanol dependent via chronic passive ethanol vapor exposure or via chronic voluntary binge drinking show similar abnormalities in expression of CRF, NPY or their cognate receptors in components of the central extended amygdala or lateral septum, brain regions that subserve anxiety-like behavior and ethanol reinforcement. Using LC-MS, immunoassay, and quantitative and functional autoradiographic techniques, studies seek to identify which neurochemical changes coincide with the
resurgence of anxiety-like behavior observed from early (2 weeks) to late (6-12 weeks) protracted withdrawal. Finally, SPECIFIC AIM 3 microinjects selective CRF and NPY receptor ligands into discrete brain regions to determine the functional relevance of neurochemical changes seen in AIM 2 for the increased anxiety of protracted withdrawal.
随着酒精依赖的发展,摄入量从有控制的饮酒转变为无控制的,强迫性的和过量的摄入。假设由慢性、重度乙醇使用(“暴饮暴食”)引起的神经适应性会推动这种进展,导致停止摄入后出现复发动机的负面影响。因此,酒精的摄入量就不得不发挥其消极的强化作用--以避免或缓解情感性戒断症状。时间进程研究表明,急性和晚期长期禁欲是不同阶段的撤退,激励饮酒和其神经生物学基础尚不清楚。行为学和神经化学数据表明下丘脑外促肾上腺皮质激素释放因子(CRF)和神经肽Y(NPY)功能失调在情感性戒断症状中的作用。本申请的首要假设是长期大量使用乙醇导致焦虑性下丘脑外CRF的增加!或Y2信号传导和抗焦虑Yi活性的降低,其中每一种都有助于延长乙醇戒断期间的“被动”焦虑行为。具体目标1将确定慢性自我管理的酗酒史是否会导致急性或长期乙醇戒断后焦虑样行为的增加。具体目标2将决定
无论是通过慢性被动乙醇蒸汽暴露还是通过慢性自愿狂饮使大鼠呈现乙醇依赖性,其在中央延伸杏仁核或侧隔的组分中CRF、NPY或其同源受体的表达均显示出类似的异常,所述中央延伸杏仁核或侧隔是有助于焦虑样行为和乙醇强化的脑区域。使用LC-MS、免疫测定以及定量和功能性放射自显影技术,研究试图确定哪些神经化学变化与神经元的功能变化一致。
从早期(2周)到晚期(6-12周)观察到的焦虑样行为的复发。最后,特异性AIM 3将选择性CRF和NPY受体配体微量注射到离散的脑区,以确定AIM 2中观察到的神经化学变化与长期戒断焦虑增加的功能相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC P ZORRILLA其他文献
ERIC P ZORRILLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC P ZORRILLA', 18)}}的其他基金
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:
10329951 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:
10544021 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Dorsal striatal phosphodiesterase 10A and compulsive ethanol use
背侧纹状体磷酸二酯酶 10A 和强迫性乙醇使用
- 批准号:
10660892 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Extrahypothalamic PPARs and compulsive food intake
下丘脑外 PPAR 和强迫性食物摄入
- 批准号:
9746543 - 财政年份:2020
- 资助金额:
$ 19.5万 - 项目类别:
Urocortins Brain CRF2 Receptors and Energy Balance
尿皮质素大脑 CRF2 受体和能量平衡
- 批准号:
8007028 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
Urocortins Brain CRF2 Receptors and Energy Balance
尿皮质素大脑 CRF2 受体和能量平衡
- 批准号:
7892017 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
Galanin Control of Food Intake: Molecular, Neuroanatomical and Behavioral Bases
甘丙肽控制食物摄入:分子、神经解剖学和行为基础
- 批准号:
7849888 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Standard Grant














{{item.name}}会员




